Delivery Order SPE2DB22D2211-SPE2DB23FNHM4
Award Date 5/15/23
Potential Completion Date 5/16/23
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order valued at $1,709.30 for AMOX-CLAV 875-125 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of May 22, 2023 and a pricing type of Firm Fixed Price. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs,...
- This federal contract award, valued at $24,757.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of AMOX-CLAV 875-125 MG TABLET 20S, a generic pharmaceutical product, with a performance period ending on May 4, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,581.72, is for the delivery of AMOX-CLAV 875-125 MG TABLET 20S, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is May 11, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,265.87 delivery order is for the supply of Amox-Clav 875-125 mg tablets, a prescription medication. The contract has a firm-fixed price and an ultimate completion date of December 15, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is a $1,068.06 firm-fixed-price delivery order for the supply of AMOX-CLAV 875-125 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of July 14, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award is a $3,383.56 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of AMOX-CLAV 875-125 MG TABLET 100S, a pharmaceutical product, with a performance period through June 17, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,668.84 delivery order contract is for the procurement of AMOX-CLAV 875-125 MG TABLET 20S, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of May 12, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $2,949.85, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of AMOX-CLAV 875-125 MG TABLET 20S, a pharmaceutical product. The award is a Delivery Order against an Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC enables...
- This federal contract award is for the delivery of Amoxicillin-Clavulanate 875-125 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,193.22, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,996.66 firm-fixed-price delivery order is for the supply of Amox-Clav 875-125 mg tablets, a common antibiotic medication. The contract has a period of performance through May 6, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial...